miR-378a-3p sensitizes ovarian cancer cells to cisplatin through targeting MAPK1/GRB2

Title
miR-378a-3p sensitizes ovarian cancer cells to cisplatin through targeting MAPK1/GRB2
Authors
Keywords
-
Journal
BIOMEDICINE & PHARMACOTHERAPY
Volume 107, Issue -, Pages 1410-1417
Publisher
Elsevier BV
Online
2018-09-01
DOI
10.1016/j.biopha.2018.08.132

Ask authors/readers for more resources

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started